Form 4 Filing for Edesa Biotech, Inc. - Officer/Director Transaction

Charles V. Olson, a director at Edesa Biotech, Inc., acquired 19,000 Common Shares on May 27, 2026, through a grant of restricted share units under the company's 2019 Equity Incentive Compensation Plan. These units will vest over twelve months. The reported transaction has a post-transaction share count of 30,000. The value of the shares and transaction price were $0.00, as indicated by footnote F1, which references the restricted share unit grant.